Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study. – PubMed – NCBI

https://www.ncbi.nlm.nih.gov/pubmed/27388574?dopt=Abstract

Amazingly, Lithium inhibits glycogen synthase, an enzyme used in cancer; therefore, lithium lowers the risk of cancer in bipolar disorder, by an average of 25%.
Not bad

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.